Results
[KCE] Press release : KCE Reports 428 Paediatric NEED Assessment Framework 2026
A new press release has been published on the web site of the KCE, the text is only available in Dutch or French. We apologize for the inconvenience. Yours sincerely, Webmaster...
Read more
Paediatric NEED Assessment Framework 2026
KCE Reports 428C (2026)
Read more
An ethical analysis of the NEED framework: exploring the moral relevance and relative ethical urgency of its criteria
KCE Reports 427C (2026)
Read more
Research methods for the evaluation of Health services & Policy initiatives
KCE Reports 426C (2026)
Read more
2026/10 - Latest news from KCE Trials
KCE Trials Newsletter – October 2026 In this issue: New funding opportunity for multinational studies with ERA4Health Results of our 2026 Calls Register now for our Symposium on 26 November New funding opportunity: IICS4all 2027 call opens on 27 October – €1.5 million...
Read more
BeNeBio: Dose reduction of the new generation biologics (IL17 and IL23 inhibitors) in psoriasis: A pragmatic, multi-centre, randomised, controlled, non-inferiority study (BeNeFIT18562)
Summary (French or English) Biologics are effective agents for the treatment of psoriasis. The newest generation of biologics block interleukin 17 and 23. Physicians always prescribe these drugs in a fixed dose, but probably, not every patient needs this.
Read more
2027 – IICS4all 2027 (ERA4Health partnership)
Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic and Non-Communicable Respiratory Diseases, including underrepresented Populations Pre-announcement Together with the ERA4Health partnership (Fostering a European Research Area for Health Research),
Read more
ALLTogether1: A trial for children and young adults with acute lymphoblastic leukaemia (ALL) (KCE-17010)
Summary (French or Dutch) Acute lymphoblastic leukemia (ALL) is the most frequent cancer in children and young adults with more than 70-80 new patients per year in Belgium (25% of all paediatric cancers).In the last decades, the chances of cure for children and young adults with ALL have greatly imp...
Read more
Contact Us
Read more
PRECISe-2: A randomised controlled, multicentre trial investigating the impact of low versus standard enteral protein provision on health-related quality of life following intensive care admission (KCE-241531)
Summary (Dutch or French) When patients survive a life-threatening condition in the intensive care unit (ICU), they often face a prolonged recovery process marked by persistent health issues that significantly reduce their quality of life.
Read more